These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7267470)

  • 41. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
    Hom C; Ilowite NT
    Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.
    McCann LJ; Pain CE
    Indian J Pediatr; 2016 Feb; 83(2):163-71. PubMed ID: 26489640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Collagen Vascular Diseases: SLE, Dermatomyositis, Scleroderma, and MCTD.
    Vehe RK; Riskalla MM
    Pediatr Rev; 2018 Oct; 39(10):501-515. PubMed ID: 30275033
    [No Abstract]   [Full Text] [Related]  

  • 44. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic criteria, severity classification and guidelines of localized scleroderma.
    Asano Y; Fujimoto M; Ishikawa O; Sato S; Jinnin M; Takehara K; Hasegawa M; Yamamoto T; Ihn H
    J Dermatol; 2018 Jul; 45(7):755-780. PubMed ID: 29687475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric scleroderma: systemic or localized forms.
    Torok KS
    Pediatr Clin North Am; 2012 Apr; 59(2):381-405. PubMed ID: 22560576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Connective tissue diseases.
    Turner ML
    Clin Plast Surg; 1993 Jan; 20(1):77-90. PubMed ID: 8420711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Combination of diabetes and scleroderma].
    Fourrier A; Mouton YJ; Montois R; Zylberberg C; Pommelet P; Vanhille P
    Sem Hop; 1973 Oct; 49(43):2853-6. PubMed ID: 4362580
    [No Abstract]   [Full Text] [Related]  

  • 49. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
    Knobler R; Geroldinger-Simić M; Kreuter A; Hunzelmann N; Moinzadeh P; Rongioletti F; Denton CP; Mouthon L; Cutolo M; Smith V; Gabrielli A; Bagot M; Olesen AB; Foeldvari I; Jalili A; Kähäri V; Kárpáti S; Kofoed K; Olszewska M; Panelius J; Quaglino P; Seneschal J; Sticherling M; Sunderkötter C; Tanew A; Wolf P; Worm M; Skrok A; Rudnicka L; Krieg T
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1251-1280. PubMed ID: 38456584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Juvenile scleroderma].
    de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
    Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic sclerosis: Current concepts of skin and systemic manifestations.
    Pearson DR; Werth VP; Pappas-Taffer L
    Clin Dermatol; 2018; 36(4):459-474. PubMed ID: 30047430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sclerodermiform skin diseases].
    Thies W
    Med Welt; 1976 Oct; 27(41):1941-6. PubMed ID: 792618
    [No Abstract]   [Full Text] [Related]  

  • 53. Scleroderma and related disorders: therapeutic aspects.
    Denton CP; Black CM
    Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
    Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C; Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1401-1424. PubMed ID: 28792092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct immunofluorescence in the diagnosis of scleroderma syndromes.
    Winkelmann RK; Carapeto FJ; Jordon RE
    Br J Dermatol; 1977 Mar; 96(3):231-8. PubMed ID: 322691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Neurological and psychological syndromes of scleroderma (author's transl)].
    Gottwald W; Benos J
    Fortschr Neurol Psychiatr Grenzgeb; 1974 May; 42(5):225-63. PubMed ID: 4603711
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical aspects of localized and systemic sclerosis.
    Clements P
    Curr Opin Rheumatol; 1992 Dec; 4(6):843-50. PubMed ID: 1457279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Scleroatrophic lichen and its relation to scleroderma].
    Kalamkarian AA; Fedorova EG
    Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.